Previous Article | Next Article 
Journal of Virology, December 2000, p. 11626-11635, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Expression of the Surface Glycoproteins of Human
Parainfluenza Virus Type 3 by Bovine Parainfluenza Virus Type 3, a
Novel Attenuated Virus Vaccine Vector
Aurelia A.
Haller,*
Tessa
Miller,
Misrach
Mitiku, and
Kathleen
Coelingh
Aviron, Mountain View, California 94043
Received 7 June 2000/Accepted 11 September 2000
Bovine parainfluenza virus type 3 (bPIV3) is being evaluated as an
intranasal vaccine for protection against human PIV3 (hPIV3). In young
infants, the bPIV3 vaccine appears to be infectious, attenuated,
immunogenic, and genetically stable, which are desirable characteristics for an RNA virus vector. To test the potential of the
bPIV3 vaccine strain as a vector, an infectious DNA clone of bPIV3 was
assembled and recombinant bPIV3 (r-bPIV3) was rescued. r-bPIV3
displayed a temperature-sensitive phenotype for growth in tissue
culture at 39°C and was attenuated in the lungs of Syrian golden
hamsters. In order to test whether r-bPIV3 could serve as a vector, the
fusion and hemagglutinin-neuraminidase genes of bPIV3 were replaced
with those of hPIV3. The resulting bovine/human PIV3 was temperature
sensitive for growth in Vero cells at 37°C. The replication of
bovine/human PIV3 was also restricted in the lungs of hamsters, albeit
not as severely as was observed for r-bPIV3. Despite the attenuation
phenotypes observed for r-bPIV3 and bovine/human PIV3, both of these
viruses protected hamsters completely upon challenge with hPIV3. In
summary, bPIV3 was shown to function as a virus vector that may be
especially suitable for vaccination of infants and children against
PIV3 and other viruses.
*
Corresponding author. Mailing address: Aviron, 297 N. Bernardo Ave., Mountain View, CA 94043. Phone: (650) 919-1408. Fax: (650) 919-6611. E-mail: ahaller{at}aviron.com.

Present address: Mayo Clinic, Rochester,
Minn.
Journal of Virology, December 2000, p. 11626-11635, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bukreyev, A., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L.
(2006). Nonsegmented negative-strand viruses as vaccine vectors.. J. Virol.
80: 10293-10306
[Full Text]
-
Schickli, J. H., Kaur, J., Ulbrandt, N., Spaete, R. R., Tang, R. S.
(2005). An S101P Substitution in the Putative Cleavage Motif of the Human Metapneumovirus Fusion Protein Is a Major Determinant for Trypsin-Independent Growth in Vero Cells and Does Not Alter Tissue Tropism in Hamsters. J. Virol.
79: 10678-10689
[Abstract]
[Full Text]
-
Baron, M. D., Banyard, A. C., Parida, S., Barrett, T.
(2005). The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes. J. Gen. Virol.
86: 1093-1101
[Abstract]
[Full Text]
-
Tang, R. S., MacPhail, M., Schickli, J. H., Kaur, J., Robinson, C. L., Lawlor, H. A., Guzzetta, J. M., Spaete, R. R., Haller, A. A.
(2004). Parainfluenza Virus Type 3 Expressing the Native or Soluble Fusion (F) Protein of Respiratory Syncytial Virus (RSV) Confers Protection from RSV Infection in African Green Monkeys. J. Virol.
78: 11198-11207
[Abstract]
[Full Text]
-
MacPhail, M., Schickli, J. H., Tang, R. S., Kaur, J., Robinson, C., Fouchier, R. A. M., Osterhaus, A. D. M. E., Spaete, R. R., Haller, A. A.
(2004). Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J. Gen. Virol.
85: 1655-1663
[Abstract]
[Full Text]
-
Pennathur, S., Haller, A. A., MacPhail, M., Rizzi, T., Kaderi, S., Fernandes, F., Bicha, L., Schickli, J. H., Tang, R. S., Chen, W., Nguyen, N., Mathie, S., Mehta, H., Coelingh, K. L.
(2003). Evaluation of attenuation, immunogenicity and efficacy of a bovine parainfluenza virus type 3 (PIV-3) vaccine and a recombinant chimeric bovine/human PIV-3 vaccine vector in rhesus monkeys. J. Gen. Virol.
84: 3253-3261
[Abstract]
[Full Text]
-
Tang, R. S., Schickli, J. H., MacPhail, M., Fernandes, F., Bicha, L., Spaete, J., Fouchier, R. A. M., Osterhaus, A. D. M. E., Spaete, R., Haller, A. A.
(2003). Effects of Human Metapneumovirus and Respiratory Syncytial Virus Antigen Insertion in Two 3' Proximal Genome Positions of Bovine/Human Parainfluenza Virus Type 3 on Virus Replication and Immunogenicity. J. Virol.
77: 10819-10828
[Abstract]
[Full Text]
-
Haller, A. A., Mitiku, M., MacPhail, M.
(2003). Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV. J. Gen. Virol.
84: 2153-2162
[Abstract]
[Full Text]
-
Henrickson, K. J.
(2003). Parainfluenza Viruses. Clin. Microbiol. Rev.
16: 242-264
[Abstract]
[Full Text]
-
Skiadopoulos, M. H., Schmidt, A. C., Riggs, J. M., Surman, S. R., Elkins, W. R., St. Claire, M., Collins, P. L., Murphy, B. R.
(2002). Determinants of the Host Range Restriction of Replication of Bovine Parainfluenza Virus Type 3 in Rhesus Monkeys Are Polygenic. J. Virol.
77: 1141-1148
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]